Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Can Making Video Narratives Benefit Adolescents With Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03127254
Recruitment Status : Not yet recruiting
First Posted : April 25, 2017
Last Update Posted : March 20, 2019
Sponsor:
Collaborators:
MetroHealth Medical Center
Palo Alto University
Information provided by (Responsible Party):
Case Comprehensive Cancer Center

Brief Summary:
The purpose of this study is to learn more about the content of and benefits of making video testimonials in adolescents with cancer.

Condition or disease Intervention/treatment Phase
Pediatric Cancer Behavioral: Video narrative Behavioral: PedsQL Behavioral: Ten Item Personality Inventory Behavioral: Delis-Kaplan Executive Function System (D-KEFS) Verbal Fluency Test Behavioral: The Cognitive Log Not Applicable

Detailed Description:

The current research aims to:

A. enlist teens with cancer to produce video narratives about their experiences with their illness B. explicitly characterize and investigate the videos' content and C. determine what aspects of the production were helpful to the teen making them and predicted to be helpful to those watching them.


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 100 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: Can Making Video Narratives Benefit Adolescents With Cancer
Estimated Study Start Date : April 2019
Estimated Primary Completion Date : December 2019
Estimated Study Completion Date : December 2020

Arm Intervention/treatment
Experimental: Video Narrative with surveys
Participants will be asked to create a 10-15 minute video narrative on their experiences after being diagnosed with cancer. Participants will also be asked to complete surveys including pediatric quality of life (PedsQL), Ten Item Personality Inventory (TIPI), Delis-Kaplan Executive Function System (D-KEFS) Verbal Fluency Test, and The Cognitive Log (Cog-Log)
Behavioral: Video narrative
create a 10-15 minute video intervention about teen experiences after being diagnosed with cancer

Behavioral: PedsQL
A generic 23-item Health Related Quality of Life measure initially developed using pediatric cancer patients
Other Name: Pediatric quality of life

Behavioral: Ten Item Personality Inventory
The TIPI consists of ten items and measures personality based the subject's agreement of descriptions of themselves taken from the Big-5 model of personality
Other Name: TIPI

Behavioral: Delis-Kaplan Executive Function System (D-KEFS) Verbal Fluency Test
The D-KEFS Verbal Fluency Test consists of three subtests, which take approximately 6 minutes to complete

Behavioral: The Cognitive Log
The Cog-Log is a 5-10 minute assessment designed to measure basic cognitive functioning and orientation
Other Name: Cog-Log




Primary Outcome Measures :
  1. linear regression of pediatric quality of life (PedsQL), TIPI, and coded themes from video narratives on coherence, subjectivity and redemption [ Time Frame: at end of intervention - Approximately 60 minutes after enrolling on study ]
    Participants' composite scores of the 10 items that make up the emotional and social domains from the PedsQL, 15 items from the PedsQL cancer module, and the two items on the TIPI that measure Extroversion will positively covary with the resilient qualities of their narrative as measured by levels of narrative coherence, subjectivity, and redemption


Secondary Outcome Measures :
  1. linear regression of coded resilient qualities of narrative with Post Video Impression Questionnaire [ Time Frame: at end of intervention - Approximately 60 minutes after enrolling on study ]
    Resilient qualities of the narrative, as measured by levels of narrative coherence, subjectivity, and redemption, will predict the sum of 16 select items on the Post Video Impressions Questionnaire identifying positive impact associated with producing the narrative

  2. linear regression of impact experienced from making the video narrative with summed scores of participants willingness to post online [ Time Frame: at end of intervention - Approximately 60 minutes after enrolling on study ]
    The sum of the 16 item composite scale measuring impact experienced from making the testimonial video, on the Post Video Impressions Questionnaire, will positively predict the summed scores of two items measuring participants' willingness to post the video online

  3. linear regression of perceived impact with summed scores of participants willingness to post the video online [ Time Frame: at end of intervention - Approximately 60 minutes after enrolling on study ]
    The sum of the 7 item composite scale measuring the perceived impact on others who watch the video, on the Post Video Impressions Questionnaire, will positively predict the summed scores of two items measuring participants' willingness to post the video online



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   11 Years to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Diagnosed with cancer
  • Patients receiving cancer treatment for the first time
  • Can complete study before high school graduation
  • Must be able to read and understand English

Exclusion Criteria:

  • Participants cannot have been treated for other chronic illnesses prior to cancer diagnosis
  • Patients with cognitive and.or verbal capacities impaired to the point where they cannot consent or assent for themselves
  • Patients who cannot communicate narratives clearly due to cognitive and/or verbal impairments

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03127254


Contacts
Layout table for location contacts
Contact: Jennifer C Anderson, PhD 216-844-7692 jennifer.anderson@uhhospitals.org

Locations
Layout table for location information
United States, Ohio
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center Not yet recruiting
Cleveland, Ohio, United States, 44106
Contact: Jennifer C Anderson, PhD    216-844-7692    jennifer.anderson@uhhospitals.org   
Principal Investigator: Jennifer C Anderson, PhD         
Metrohealth Medical Center Not yet recruiting
Cleveland, Ohio, United States, 44109
Contact: Lila Pereira    845-642-7385    lpereira@paloaltou.edu   
Principal Investigator: Lila Pereira         
Sponsors and Collaborators
Case Comprehensive Cancer Center
MetroHealth Medical Center
Palo Alto University
Investigators
Layout table for investigator information
Principal Investigator: Jennifer C Anderson, PhD University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center

Layout table for additonal information
Responsible Party: Case Comprehensive Cancer Center
ClinicalTrials.gov Identifier: NCT03127254     History of Changes
Other Study ID Numbers: CASE12Z16
First Posted: April 25, 2017    Key Record Dates
Last Update Posted: March 20, 2019
Last Verified: March 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Case Comprehensive Cancer Center:
Video Narrative